Contact

Ingenuity Impact – 2024

Back to Competitions

Ingenuity Impact is a national innovation and entrepreneurship programme that directly addresses the UK’s major social, health and environmental challenges through the creation of impactful start-ups. The programme is inclusive, diverse and accessible for all and supports students, alumni and community members nationally to turn ideas for change into exciting new ventures. Now in its ninth year, the programme is designed to demystify entrepreneurship and support underserved and underrepresented groups to engage by adopting an agile and flexible approach.

First place: Circlone

Blue ocean strategy company Circlone aims to support young children in transitioning online safely and accountably.

Circlone is reinventing digital communication as the leading AI-powered, verified-only communication platform for children aged eight and above to transition online in a safe and accountable way through a verified-only platform which creates accountability and enforces moderation.

Specifically built features allow parental safeguarding, whilst letting youngsters flourish in a growingly digital world. Its safeguarding dashboard lets guardians control who children can contact, adjust what content they can share, receive SMS and email alerts with safeguarding-related updates and restrict the level of content filtration.

Student:

  • Rupert Lowe – Computer Science with AI

Prize awarded: £1,500

Also pictured: EIBF President, David Falzani MBE (left)

Second place: PLURABIO

PLURABIO is an impact-driven business tackling a lack of genetic diversity in preclinical drug testing induces racial disparities in drug efficacy and safety across populations. PLURABIO will tackle this issue by bringing to market genetically diverse, easy to use and flexible in vitro 3D models for drug development and testing.

Student:

  • Dr Inchirah Adala – Regenerative Medicine

Prize awarded: £1,000

Also pictured: EIBF President, David Falzani MBE (left)

Third place: Medscribe

Medscribe addresses the administrative burden currently faced by clinicians in the NHS, offering impressive time savings and empowering clinicians to refocus on providing safe, high-quality patient care.

Medscribe presents an innovative, Al-powered clinical documentation solution that is fast, safe, and affordable. Its software drastically cuts down the time clinicians spend on paperwork, achieving an impressive 86% reduction in letter-writing time, with computation now optimised to less than two seconds per letter. By reducing administrative workloads, Medscribe empowers clinicians to refocus on providing quality patient care.

With regulatory compliance well underway, and trials planned for later this year, Medscribe will be ready for market entry in 2025.

Student:

  • Henry James – Medicine

Prize awarded: £500

Also pictured: EIBF President, David Falzani MBE (left)